BMO Capital analyst Evan David Seigerman lowered the price target on Amgen (NASDAQ: AMGN) to $335.00 (from $346.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE